CIK 0001087294 · Non-accelerated filer<br>Smaller reporting company
CUMBERLAND PHARMACEUTICALS INC
Sign in to watch- Ticker
- CPIX
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- TN
- Entity type
- operating
- EIN
- 621765329
- Phone
- 615-255-0068
- Business address
- 1600 WEST END AVENUE, SUITE 1300, NASHVILLE,, TN, 37203
- 4 Open-market buy Director bought 2,982 shares at an average $2.72 ($8,112)
- 4 Open-market buy Director bought 882 shares at an average $2.72 ($2,399)
- 4 Open-market buy Director bought 315 shares at an average $2.72 ($857)
- 4 Open-market buy Chairman and CEO bought 315 shares at an average $2.72 ($857)
- 4 Open-market buy Director bought 1,785 shares at an average $2.72 ($4,856)
- 4 Open-market buy Sr VP/Chief Commercial Officer bought 2,205 shares at an average $2.72 ($5,999)
- 4 Open-market buy Director bought 2,982 shares at an average $2.83 ($8,436)
- 4 Open-market buy Director bought 882 shares at an average $2.83 ($2,495)
- 4 Open-market buy Director bought 315 shares at an average $2.83 ($891)
- 4 Open-market buy Chairman and CEO bought 315 shares at an average $2.83 ($891)
- 4 Open-market buy Director bought 1,785 shares at an average $2.83 ($5,050)
- 4 Open-market buy Sr VP/Chief Commercial Officer bought 2,205 shares at an average $2.83 ($6,238)
- 4 Open-market buy Chairman and CEO bought 315 shares at an average $2.98 ($938)
- 4 Open-market buy Chairman and CEO bought 315 shares at an average $3.27 ($1,029)
- 4 Open-market buy Chairman and CEO bought 345 shares at an average $3.04 ($1,049)
- 4 Open-market buy Chairman and CEO bought 450 shares at an average $2.88 ($1,295)
- 4 Open-market buy Director bought 315 shares at an average $2.98 ($938)
- 4 Open-market buy Director bought 315 shares at an average $3.27 ($1,029)
- 4 Open-market buy Director bought 345 shares at an average $3.04 ($1,049)
- 4 Open-market buy Director bought 450 shares at an average $2.88 ($1,295)
Page 11 of 26 · 512 filings